Neuroendocrine Tumor Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CRNX | C | Crinetics Pharmaceuticals, Inc. | 1.71 | |
ABUS | D | Arbutus Biopharma Corporation | 0.58 | |
AQST | D | Aquestive Therapeutics, Inc. | -4.75 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
HRTS | F | Tema Cardiovascular and Metabolic ETF | 4.0 | |
MNTL | D | Tema Neuroscience and Mental Health ETF | 3.88 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 2.95 | |
BBC | F | Virtus LifeSci Biotech Clinical Trials ETF | 2.01 | |
PTH | D | Invesco DWA Healthcare Momentum ETF | 1.68 |
Compare ETFs
Related Industries:
Biotechnology
- Neuroendocrine Tumor
A neuroendocrine tumor (NET) is a type of cancer that develops from cells of the neuroendocrine system. This system is made up of cells that release hormones in response to signals from the nervous system. Neuroendocrine tumors can occur anywhere in the body and can be benign (non-cancerous) or malignant (cancerous). Symptoms of NETs vary depending on the location and type of tumor, but may include abdominal pain, diarrhea, weight loss, and fatigue. Treatment options may include surgery, chemotherapy, radiation, and targeted therapy.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles